Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Laminaria japonica* (synonym *Saccharina japonica*), commonly known as kombu or haidai, is a large brown seaweed (kelp) native to the Northwest Pacific. In clinical practice, the dried, sterilized stalks of the plant are utilized as osmotic dilators (laminaria tents) to facilitate cervical ripening and dilation prior to gynecological procedures such as intrauterine device insertion or surgical abortion. The plant is also a significant dietary source of iodine, used to prevent and treat iodine deficiency disorders like goiter. Beyond its physical and nutritional applications, *Laminaria japonica* contains bioactive polysaccharides, including fucoidan and laminarin, which exhibit anticoagulant, antioxidant, and immunomodulatory activities in preclinical models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on laminaria japonica.